A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees and including effective date provisions.(Formerly SSB 1017.)
Summary
SF 315 creates a new framework for the Iowa Department of Administrative Services to procure pharmacy benefits manager (PBM) services for self-funded public sector health plans through an online reverse auction process. The bill defines a “pharmacy benefits manager reverse auction” as a transparent, competitive bidding process in which qualified PBMs can repeatedly lower their bids, and it requires the state to use a technology platform capable of normalizing claims data, comparing complex pricing models, and producing bid rankings and reports. The bill also requires the platform to be repurposed to adjudicate pharmacy claims and review invoices line by line after the contract is awarded.
The measure sets deadlines for procurement and implementation, including a first reverse auction and contract effective date beginning January 1, 2026. It also allows later participation by other self-funded public sector health plans after the first contract has been in place for three years, while preserving each plan’s autonomy over formularies and benefit design. The bill excludes certain nonprofit, nongovernmental HMOs and allows the department to conduct a market check during the contract term or even vacate an auction result if the lowest bid does not beat the incumbent’s projected cost trend.
Impact
SF 315 would amend Iowa law by adding a new section to chapter 8A governing how the state procures PBM services for self-funded public sector health plans, including state employee health coverage under chapter 509A. It would require the Department of Administrative Services to use a reverse-auction procurement model, establish technical and contracting standards for the auction platform, prohibit contracting with PBM-affiliated vendors for the platform, and require ongoing claims reconciliation against contract terms. The bill could affect PBMs, technology vendors, state health plans, and retirees in Medicare Part D employer group waiver programs by changing how prescription drug benefit administration is competitively sourced and monitored.
Sentiment
The bill appears to have been received positively in the legislative process, with unanimous committee and floor votes reflected in the available history. The Senate Health and Human Services Committee reported the bill 14-0, the Senate passed it 45-0, and the House Agriculture Committee reported it 20-0. That voting pattern suggests broad bipartisan support for the bill’s goal of increasing transparency and competition in PBM contracting.
Contention
No committee transcript is available, and the recorded votes show no formal opposition, so there is little direct evidence of controversy in the provided materials. The main policy tensions inherent in the bill are between cost containment and procurement flexibility on one hand, and concerns about the complexity of PBM pricing, the feasibility of reverse auctions, and the administrative burden of line-by-line claims adjudication on the other. The bill also draws a distinction between active employees and retiree Medicare Part D waiver groups, which could be a point of operational concern for affected health plans, though no specific objections are documented here.
A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.